Clinical trialNCT05124912RecruitingInterventional

REMASTer: REcurrent Brain Metastases After SRS Trial

SponsorMonteris MedicalEnrollment261Brain MetastasesRadiation NecrosisRecurrent MetastasesRecurrent Tumor

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Randomized, post-market multi-center study investigating the efficacy of two sets of treatment algorithms in brain metastases (BM) patients at the time of first intervention for radiographic progression after stereotactic radiosurgery (SRS), with or without surgery.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Peter Fecci, MD
University of Colorado, Denver
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Ucla
Los Angeles, California, United States
Won Kim, MD
Recruiting
University of Chicago
Chicago, Illinois, United States
Peter Warnke, MD
Recruiting
University of Maryland
Baltimore, Maryland, United States
Mark Mishra, MD
Recruiting
Washu
St Louis, Missouri, United States
Albert Kim, MD, PhD
Recruiting
Duke University Hospital
Durham, North Carolina, United States
Active, not recruiting
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, United States
Adrian Laxton, MD
Recruiting
Cleveland Clinic
Cleveland, Ohio, United States
Matthew Grabowski, MD
Recruiting
Kettering Health
Kettering, Ohio, United States
Anthony Paravati, MD
Recruiting
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Max Krucoff, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Steroid Therapy

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 10 May 2022
Primary completion: 31 Dec 2026
Completion: 31 Oct 2028
Last update posted: 18 Jun 2026
Registered enrollment: 261
Registry id: NCT05124912

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.